Overview

Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria

Status:
Terminated
Trial end date:
2004-01-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide daptomycin, an antibiotic, to patients who are failing conventional therapy, or who cannot take approved antibiotics for one reason or another.
Phase:
Phase 3
Details
Lead Sponsor:
Cubist Pharmaceuticals LLC
Treatments:
Daptomycin